Genmab — Juni 2019
-
to be complete, this is the article in the Lancet on CASSIOPEIA https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31240-1/fulltext and full text in pdf https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673619312401.pdf
-
Nogen, der kender til tidslinjen for SC? Hvornår forventes ansøgning sendt? Vi kan vel forvente priority review? Og hvor længe skal FDA bruges til det? Sidst på baggrund af Cassiopeia kun 4 mdr.
-
E L ? "just on some of the comments on investor conferences, Genmab's Upcoming Investor & Other Events: UBS Global Healthcare Conference, May 20-22 Jefferies Global Healthcare Conference, June 4-6 Goldman Sachs Healthcare Conference, June 11-13 JP Morgan European Healthcare Conference, June 20"
-
-
Fra årsrapporten: Upcoming Investor & Other Events
Carnegie Healthcare Seminar 2019, March 5
Genmab Annual General Meeting, March 29
H.C. Wainright Global Life Science Conference, April 9
Kempen Life Sciences Conference, April 16-17 - Ingen af disse, bortset fra genfors, har de deltaget i iflg hjemmeside. -
Nu har jeg kigget dagsordenen igennem 2 gange og kan ikke finde Genmab. Men de står på deltagerlisten på sidste side https://www.ubs.com/global/en/investment-bank/conferences/global.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Some were wondering why Genmab was not participating in any investor conferences anymore, but they are